about
Gonadotropin-releasing hormone receptorsDiversity of actions of GnRHs mediated by ligand-induced selective signalingA protocol for RNA methylation differential analysis with MeRIP-Seq data and exomePeak R/Bioconductor package.Gonadotropin-releasing hormone analog structural determinants of selectivity for inhibition of cell growth: support for the concept of ligand-induced selective signaling.The conformational switch in 7-transmembrane receptors: the muscarinic receptor paradigm.Helix 8 of the M1 muscarinic acetylcholine receptor: scanning mutagenesis delineates a G protein recognition site.The multifunctional poly(A)-binding protein (PABP) 1 is subject to extensive dynamic post-translational modification, which molecular modelling suggests plays an important role in co-ordinating its activities.Antiproliferative effects of GnRH agonists: prospects and problems for cancer therapy.Role of the transmembrane domain 4/extracellular loop 2 junction of the human gonadotropin-releasing hormone receptor in ligand binding and receptor conformational selection.A crucial role for Galphaq/11, but not Galphai/o or Galphas, in gonadotropin-releasing hormone receptor-mediated cell growth inhibition.Mammalian type I gonadotropin-releasing hormone receptors undergo slow, constitutive, agonist-independent internalization.Evolution of constrained gonadotropin-releasing hormone ligand conformation and receptor selectivity.Identification of Tyr(290(6.58)) of the human gonadotropin-releasing hormone (GnRH) receptor as a contact residue for both GnRH I and GnRH II: importance for high-affinity binding and receptor activation.Identification of a novel ligand binding residue Arg38(1.35) in the human gonadotropin-releasing hormone receptor.Mutations remote from the human gonadotropin-releasing hormone (GnRH) receptor-binding sites specifically increase binding affinity for GnRH II but not GnRH I: evidence for ligand-selective, receptor-active conformations.Bovine and ovine gonadotropin-releasing hormone (GnRH)-II ligand precursors and type II GnRH receptor genes are functionally inactivated.Structural determinants for ligand-receptor conformational selection in a peptide G protein-coupled receptor.Impaired P2X signalling pathways in renal microvascular myocytes in genetic hypertension.Functional examination of novel kisspeptin phosphinic peptides.Enhancing Epitranscriptome Module Detection from m6A-Seq Data Using Threshold-Based Measurement Weighting Strategy.Molecular Genetic Analysis of Normosmic Hypogonadotropic Hypogonadism in a Turkish Population: Identification and Detailed Functional Characterization of a Novel Mutation in the Gonadotropin-Releasing Hormone Receptor GeneConserved Amino Acid Residues that Are Important for Ligand Binding in the Type I Gonadotropin-Releasing Hormone (GnRH) Receptor Are Required for High Potency of GnRH II at the Type II GnRH ReceptorWHISTLE: a high-accuracy map of the human N6-methyladenosine (m6A) epitranscriptome predicted using a machine learning approachTopological Characterization of Human and Mouse m5C Epitranscriptome Revealed by Bisulfite Sequencing.[Immunomodulatory effects of polysaccharide of Cistanche Deserticola Y C Ma]A network of conserved intramolecular contacts defines the off-state of the transmembrane switch mechanism in a seven-transmembrane receptorThe role of the aspartate-arginine-tyrosine triad in the m1 muscarinic receptor: mutations of aspartate 122 and tyrosine 124 decrease receptor expression but do not abolish signalingScanning mutagenesis of transmembrane domain 3 of the M1 muscarinic acetylcholine receptor
P50
Q28256257-82152001-38BB-4CA8-AB1D-633D08DA6FB3Q30439870-9318D050-D06A-4633-AD96-0BE3BD63008CQ30834080-94BAB7EC-D884-4E83-821E-ADF9B7318AF0Q33642701-E530ADD0-82AD-44CA-8AF8-DA30942E8A6BQ33709285-D35416D1-AB8E-4CE1-B063-27828FE763CCQ34715575-30CBEA1E-4F43-4075-B29A-264DAA68C8BAQ35818175-727301C0-CBB6-4850-A4D2-1D57D90D672AQ37097839-43334138-992E-4C60-83E5-DD3F8AE09354Q38621958-9CB10698-9D4A-48B4-9510-D2B2CAF303E8Q39938380-DD78E34D-AC28-4657-BCA5-F9A1050C4067Q40044419-5268A3DC-4CF1-4996-A258-C4885FD1CBBAQ40374579-FCBD1022-B556-40EA-9A05-58649F4D77C0Q46389997-BDCD3927-6666-4890-900C-B48D308D46A3Q46945416-A8ADC8BE-FF6C-494D-9CA7-D6FF2D195A63Q52564801-9C4E2B17-75BB-401E-9EB9-6F9E9E4E3353Q52572933-202F908E-4BDD-4ED7-B156-F956F6F2B6BDQ52578645-7B4450F7-D181-42D8-B965-B0BF11DFAEC4Q52992050-E8FA2B1B-894D-439B-AA0F-0F2C48BEE282Q55106911-466736DD-5CBF-4DF7-BC8F-D8B0950F9E4EQ55663593-A3D49D58-9B79-4497-90ED-EE550C709F62Q57840283-2C9B7034-F308-4745-BA96-0AC58D617B07Q58853687-62DFBD34-8F27-432A-BD1D-CFD31D3E35BCQ64230165-C1D3AB14-DD88-40CE-8981-5BEFAEBF76E1Q64904098-2ECCD408-E37B-4B03-9A2E-97F03251126FQ73038423-4B4ADDCC-FB80-4CCD-9716-0AF42D9B4955Q73462978-2EDCC667-2D3A-4C38-9605-DBCC9AE44A07Q73467339-7805828F-BFC1-4F36-BC7E-0971604F7901Q77468553-BF164AF8-0D7E-4BC7-858B-D879ABFB521F
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Zhi-Liang Lu
@ast
Zhi-Liang Lu
@en
Zhi-Liang Lu
@es
Zhi-Liang Lu
@nl
type
label
Zhi-Liang Lu
@ast
Zhi-Liang Lu
@en
Zhi-Liang Lu
@es
Zhi-Liang Lu
@nl
prefLabel
Zhi-Liang Lu
@ast
Zhi-Liang Lu
@en
Zhi-Liang Lu
@es
Zhi-Liang Lu
@nl
P106
P31
P496
0000-0002-3442-1415